The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties

被引:466
作者
Bennett, Robert M. [1 ]
Friend, Ronald [1 ,2 ]
Jones, Kim D. [1 ]
Ward, Rachel [1 ]
Han, Bobby K. [3 ]
Ross, Rebecca L. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Fibromyalgia Res Unit, Portland, OR 97239 USA
[2] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA
[3] Phys Bldg Grp, Salem, OR 97302 USA
关键词
VISUAL ANALOG SCALES; QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; HEALTH; PAIN; DISABILITY; SF-36; SYMPTOMS; FORMATS; TRIALS;
D O I
10.1186/ar2783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The Fibromyalgia Impact Questionnaire (FIQ) is a commonly used instrument in the evaluation of fibromyalgia ( FM) patients. Over the last 18 years, since the publication of the original FIQ, several deficiencies have become apparent and the cumbersome scoring algorithm has been a barrier to widespread clinical use. The aim of this paper is to describe and validate a revised version of the FIQ: the FIQR. Methods The FIQR was developed in response to known deficiencies of the FIQ with the help of a patient focus group. The FIQR has the same 3 domains as the FIQ ( that is, function, overall impact and symptoms). It differs from the FIQ in having modified function questions and the inclusion of questions on memory, tenderness, balance and environmental sensitivity. All questions are graded on a 0-10 numeric scale. The FIQR was administered online and the results were compared to the same patient's online responses to the 36-Item Short Form Health Survey (SF-36) and the original FIQ. Results The FIQR was completed online by 202 FM patients, 51 rheumatoid arthritis ( RA) or systemic lupus erythematosus (SLE) patients ( 31 RA and 20 SLE), 11 patients with major depressive disorder (MDD) and 213 healthy controls (HC). The mean total FIQR score was 56.6 +/- 19.9 compared to a total FIQ score of 60.6 +/- 17.8 (P < 0.03). The total scores of the FIQR and FIQ were closely correlated (r = 0.88, P < 0.001). Each of the 3 domains of the FIQR correlated well with the 3 related FIQ domains (r = 0.69 to 0.88, P < 0.01). The FIQR showed good correlation with comparable domains in the SF-36, with a multiple regression analysis showing that the three FIQR domain scores predicted the 8 SF-36 subscale scores. The FIQR had good discriminant ability between FM and the 3 other groups; total FIQR scores were HC (12.1 +/- 11.6), RA/SLE (28.6 +/- 21.2) and MDD (17.3 +/- 11.8). The patient completion time was 1.3 minutes; scoring took about 1 minute. Conclusions The FIQR is an updated version of the FIQ that has good psychometric properties, can be completed in less than 2 minutes and is easy to score. It has scoring characteristics comparable to the original FIQ, making it possible to compare past FIQ results with future FIQR results.
引用
收藏
页数:14
相关论文
共 25 条
[1]  
Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154
[2]   Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen [J].
Bennett, RM ;
Schein, J ;
Kosinski, MR ;
Hewitt, DJ ;
Jordan, DM ;
Rosenthal, NR .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (04) :519-527
[3]   An internet survey of 2,596 people with fibromyalgia [J].
Bennett, Robert M. ;
Jones, Jessie ;
Turk, Dennis C. ;
Russell, I. Jon ;
Matallana, Lynne .
BMC MUSCULOSKELETAL DISORDERS, 2007, 8 (1)
[4]   Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire [J].
Bennett, Robert M. ;
Bushmakin, Andrew G. ;
Cappelleri, Joseph C. ;
Zlateva, Gergana ;
Sadosky, Alesia B. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) :1304-1311
[5]   The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey [J].
Birtane, Murat ;
Uzunca, Kaan ;
Tastekin, Nurettin ;
Tuna, Hakan .
CLINICAL RHEUMATOLOGY, 2007, 26 (05) :679-684
[6]  
BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728
[7]   Evaluating the effectiveness of visual analog scales - A web experiment [J].
Couper, MP ;
Tourangeau, R ;
Conrad, FG ;
Singer, E .
SOCIAL SCIENCE COMPUTER REVIEW, 2006, 24 (02) :227-245
[8]  
Dunkl PR, 2000, J RHEUMATOL, V27, P2683
[9]   Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, RH ;
Turk, DC ;
Farrar, JT ;
Haythornthwaite, JA ;
Jensen, MP ;
Katz, NP ;
Kerns, RD ;
Stucki, G ;
Allen, RR ;
Bellamy, N ;
Carr, DB ;
Chandler, J ;
Cowan, P ;
Dionne, R ;
Galer, BS ;
Hertz, S ;
Jadad, AR ;
Kramer, LD ;
Manning, DC ;
Martin, S ;
McCormick, CG ;
McDermott, MP ;
McGrath, P ;
Quessy, S ;
Rappaport, BA ;
Robbins, W ;
Robinson, JP ;
Rothman, M ;
Royal, MA ;
Simon, L ;
Stauffer, JW ;
Stein, W ;
Tollett, J ;
Wernicke, J ;
Witter, J .
PAIN, 2005, 113 (1-2) :9-19
[10]  
Häuser W, 2008, SCHMERZ, V22, P176, DOI 10.1007/s00482-007-0602-z